National and Kapodistrian University of Athens
Ο ρόλος του γονιδίου JunB στην παθογένεια του αναπλαστικού λεμφώματος απο μεγάλα κύτταρα
Abstract
dc:descriptionALK+ anaplastic large cell lymphoma (ALCL) frequently carries the t(2;5) translocation leading to overexpression and activation of NPM-ALK oncoprotein. Previous studies have shown that NPM-ALK is capable of activating ERK kinase and induces expression of JunB through Ets-1 transcription factor. Moreover, JunB directly interacts with the promoter of CD30 receptor gene, a member of the TNF family, resulting in CD30 upregulation, which invariably characterizes NPM-ALK+ ALCL tumors. In this study, we demonstrate for first time that, apart from its transcriptional control by ERK/Ets, JunB gene is frequently amplified in NPM-ALK+ ALCL tumors, thus further contributing to JunB overexpression. We also show that CD30 and JunB may substantially contribute to increased AP-1 activity observed in ALK+ ALCL cells and promote cell proliferation through regulation of cell cycle in vitro. Silencing of JunB gene using siRNA was associated with G1/S and G2/M cell cycle arrest, downregulation of cyclins A, D2 and D3 and upregulation of CDK inhibitors p14 and p21 in NPM-ALK+ cells. Furthermore, knocking down JunB led to reduced colony formation indicating its oncogenic potential in ALK+ ALCL cells. Similar changes on cell cycle were observed following silencing of CD30 gene or inhibition of its function using SGN30 antibodies, which additionally led to increased apoptosis in our NPM-ALK+ ALCL in vitro system. Silencing of JunB gene also sensitized NPM-ALK+ ALCL cells to standard chemotherapeutic agents. Taken together, our findings suggest that JunB may exert oncogenic activities through regulation of cell cycle, cell proliferation and survival in NPM-ALK+ ALCL cells, and these biologic effects partly involve CD30 signaling further supporting the use of anti-CD30 therapies in these tumors.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ατσαβές, Βασίλειος
- Atsaves, Vasilios
Subjects
dc:subject × 20- Αναπλαστικό λέμφωμα από μεγάλα κύτταρα
- Αναπλαστική κινάση
- Λεμφώματα
- Κυτταρικός κύκλος
- Χημειοθεραπεία
- Μονοκλωνικό αντίσωμα
- Μεταγραφικοί παράγοντες
- Επιβίωση
- JunB
- ALK
- Anaplastic large cell lymphoma
- CD30
- Cell cycle
- SGN30
- Chemotherapy
- AP1
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31762